{"organizations": [], "uuid": "7c44c6a1ec4ed1785e64281c96171fe6b799fe72", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-diplomat-reaffirms-2017-guidance-a/brief-diplomat-reaffirms-2017-guidance-and-provides-preliminary-2018-outlook-idUSASB0BZWN", "country": "US", "domain_rank": 408, "title": "BRIEF-Diplomat Reaffirms 2017 Guidance And Provides Preliminary 2018 Outlook", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-05T16:16:00.000+02:00", "replies_count": 0, "uuid": "7c44c6a1ec4ed1785e64281c96171fe6b799fe72"}, "author": "", "url": "https://www.reuters.com/article/brief-diplomat-reaffirms-2017-guidance-a/brief-diplomat-reaffirms-2017-guidance-and-provides-preliminary-2018-outlook-idUSASB0BZWN", "ord_in_thread": 0, "title": "BRIEF-Diplomat Reaffirms 2017 Guidance And Provides Preliminary 2018 Outlook", "locations": [], "entities": {"persons": [{"name": "ben wolin", "sentiment": "none"}, {"name": "jeff park", "sentiment": "none"}, {"name": "phil hagerman", "sentiment": "none"}], "locations": [], "organizations": [{"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 5, 2018 / 2:16 PM / Updated 7 minutes ago BRIEF-Diplomat Reaffirms 2017 Guidance And Provides Preliminary 2018 Outlook Reuters Staff \nJan 5 (Reuters) - Diplomat Pharmacy Inc: \n* DIPLOMAT PHARMACY INC - ‍JEFF PARK, HAS BEEN APPOINTED INTERIM CHIEF EXECUTIVE OFFICER, EFFECTIVE IMMEDIATELY​ \n* DIPLOMAT PHARMACY INC - PHIL HAGERMAN TO CONTINUE SERVICE ON BOARD AND BECOME CHAIRMAN EMERITUS \n* DIPLOMAT PHARMACY INC - BOARD HAS APPOINTED BEN WOLIN, INDEPENDENT LEAD DIRECTOR, AS CHAIRMAN OF DIPLOMAT BOARD, EFFECTIVE IMMEDIATELY \n* DIPLOMAT INITIATES CEO TRANSITION; REAFFIRMS 2017 GUIDANCE AND PROVIDES PRELIMINARY 2018 OUTLOOK \n* DIPLOMAT PHARMACY - ‍PARK‘S APPOINTMENT FOLLOWS RETIREMENT OF PHIL HAGERMAN \n* DIPLOMAT PHARMACY INC - IN 2018, DIPLOMAT PRELIMINARILY EXPECTS REVENUE IN RANGE OF $5.3 TO $5.6 BILLION Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-05T16:16:00.000+02:00", "crawled": "2018-01-05T16:33:08.024+02:00", "highlightTitle": ""}